0001179110-13-004098.txt : 20130305 0001179110-13-004098.hdr.sgml : 20130305 20130305100314 ACCESSION NUMBER: 0001179110-13-004098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130301 FILED AS OF DATE: 20130305 DATE AS OF CHANGE: 20130305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EYLENBOSCH HILDE CENTRAL INDEX KEY: 0001272540 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16789 FILM NUMBER: 13664121 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: C/O INVERNESS MEDICAL INNOVATIONS INC CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALERE INC. CENTRAL INDEX KEY: 0001145460 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 043565120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7816473900 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC DATE OF NAME CHANGE: 20010720 4 1 edgar.xml FORM 4 - X0306 4 2013-03-01 0 0001145460 ALERE INC. ALR 0001272540 EYLENBOSCH HILDE 51 SAWYER ROAD, SUITE 200 WALTHAM 02453 0 1 0 0 President, Alere International Common Stock 2013-03-01 4 M 0 2500 16.20 A 32636 D Common Stock 2013-03-01 4 S 0 2391 22.687 D 30245 D Common Stock 43143 I Spouse Common Stock 3248 D Employee Stock Option (Right to Buy) 16.20 2013-03-01 4 M 0 2500 D 2004-03-10 2013-03-10 Common Shares 2500 0 D Reresents sell to cover exercise of expiring stock options. The sales reported on this Form 4 were effected purusant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2012. The price represents the average purchase price for 14 separate transactions reported on this line. The price of the transactions reported on this line range from $22.68 to $22.70. The reporting person hereby undertakes to provide upon request to the SEC,the issuer or any stockholder of the issuer the full informaiton regarding the number of shares and prices at which the transaction was effected. This reporting person disclaims beneficial ownership of the reported securities. These securities are jointly owned with the reporting person's spouse. This derivative security does not have a price. /s/ Jay McNamara, Attorney-in-Fact 2013-03-05